Bottom line
QAAHBX vs JDOC: the short answer
QAAHBX (T. Rowe Price Health Sciences Portfolio) and JDOC (JPMorgan Healthcare Leaders ETF) are both etfs.
But QAAHBX is far broader, holding 277 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
JDOC is cheaper at 0.65% vs 1.11% — a difference of $46 a year per $10,000 invested.
Over one year, QAAHBX returned +17.8% vs +14.9% for JDOC.
Updated Nov 19, 2026
QAAHBX vs JDOC side by side
| QAAHBX | JDOC | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | T. Rowe Price | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.11% | 0.65% |
| Annual cost per $10k | $111 | $65 |
| 10-yr cost on $10k (prospectus) | $1,352 | $810 |
| Max front load | None | None |
| 12b-1 fee | 0.25% | — |
| 1-yr return | +17.8% | +14.9% |
| 5-yr return (annualized) | +3.9% | — |
| 10-yr return (annualized) | +8.7% | — |
| Best quarter | +23.4% | +11.3% |
| Worst quarter | −15.8% | −11.9% |
| Net assets (fund) | $751.7M | $9.1M |
| Number of holdings | 277 | 61 |
| Portfolio turnover | 65% | 92% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
13 of QAAHBX's top 25 holdings also appear in JDOC's top 25.
| Holding | QAAHBX | JDOC |
|---|---|---|
| Eli Lilly & Co | 14.06% | 7.76% |
| Johnson & Johnson | 6.64% | 4.82% |
| Unitedhealth Group Inc | 5.88% | 5.85% |
| Abbvie Inc | 5.12% | 7.85% |
| Merck & Co. Inc. | 4.00% | 4.82% |
| Thermo Fisher Scientific Inc | 2.53% | 3.73% |
| Bristol-myers Squibb Co | 2.12% | 3.57% |
| Abbott Laboratories | 1.91% | 3.11% |
| Intuitive Surgical Inc | 1.89% | 1.93% |
| Stryker Corp | 1.78% | 2.23% |
| Danaher Corp | 1.44% | 2.16% |
| Cardinal Health Inc | 1.04% | 1.51% |
| Cvs Health Corp | 0.93% | 2.83% |
Source: SEC Form N-PORT
QAAHBX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between QAAHBX and JDOC?
Which is cheaper, QAAHBX or JDOC?
Should I own both QAAHBX and JDOC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.